Stocks to buy

Earlier this month, reversing my initial bearishness towards Churchill Capital IV (NYSE:CCIV) stock, I became a fan of the name . While I’m still concerned about the stock’s reliance on future projections, this SPAC (special purpose acquisition company) appeared to be worth the risk. Source: Around the World Photos / Shutterstock.com How’s the stock performed
0 Comments
At the end of January, I recommended that investors looking to avoid the “dizzying valuations” that many tech names had reached consider fiber optic names, which could also be classified as 5G stocks. I pointed out that, “In a sense, the fiber optics sector is an obscure group within a partially forgotten catalyst” of 5G.
0 Comments
After Ayro (NASDAQ:AYRO) announced a promising partnership and unveiled a new electric vehicle (EV) that I believe has a great deal of potential, the outlook of AYRO stock continues to be very favorable. Source: Alexandru Nika / Shutterstock.com Further, certain aspects of Ayro’s recent sales of its new shares bode well for its stock price.
0 Comments
Despite an up-and-down performance so far in 2021, Nano Dimension (NASDAQ:NNDM) stock has had an extraordinary 12-month run. Source: shutterstock.com/Alex_Traksel The Israeli 3D printing company is up only 1.65% year-to-date, but that includes wild swings that saw the NNDM stock price soar by 83% and tumble by more than 50%. Over the last 12 months,
0 Comments
Founded during the financial crisis year of 2009, advertising automation platform Trade Desk (NASDAQ:TTD) has survived tough times and prevailed. Along with that, TTD stock traders have endured plenty of ups and downs, yet prospered in the long run. Source: BrightSpace / Shutterstock.com However, not every investor is 100% satisfied. That’s because the share price has
0 Comments
New Jersey-based Citius Pharmaceuticals (NASDAQ:CTXR) could simply be pigeonholed as a medical product company. But that’s an oversimplification. Prospective CTXR stock investors deserve a much more in-depth discussion of this fascinating company. Source: Iryna Imago / Shutterstock.com Citius describes itself as a “late-stage specialty pharmaceutical company” that develops and commercializes “critical care products, with a particular
0 Comments
Sentiment on Wall Street is somewhat sour. This is in spite of three out of four indices making new highs last week. Perception that stocks are suffering is overcoming the reality of the strength in equity. This is perhaps because of weakness in the largest mega-cap stocks in the Nasdaq. It’s the only index that
0 Comments
TPG Pace Beneficial Finance (NYSE:TPGY) stock is down 21% in the last month, giving investors the perfect opportunity to snap it up before its eventual merger  with EVBox Group, a global provider of smart-charging solutions for electric vehicles (EVs). Source: Nick Starichenko/InvestorPlace.com This “blank check company” ticks off all the boxes and then some. TPG
0 Comments